by Bradley J. Fikes
What is happening with Alzheimer’s disease research and treatment? We heard from Maria Carrillo, chief science officer of the nationwide Alzheimer’s Association, during a recent visit to San Diego. Here are some questions and answers from the interview, edited for space and clarity.
Q: There have been several failed clinical trials of monoclonal antibody drugs designed to stop or remove toxic proteins. Is that approach dead?
A: I would say it is not dead in the water—yet—because there still are a…
